期刊文献+

2型糖尿病患者甲真菌病临床资料分析 被引量:1

Clinical data analysis of onychomycosis in patients with type 2 diabetes
原文传递
导出
摘要 目的了解糖尿病患者甲真菌病的临床分型、菌种构成及易感因素。方法分析2013年1月至2014年8月山西医科大学第二医院内分泌科2型糖尿病住院患者的临床资料,对合并甲真菌病者进行临床分型、菌种鉴定,对可能导致糖尿病患者甲真菌感染的因素进行Logistic回归分析。结果 1 125例2型糖尿病患者中合并有甲真菌病者153例,患病率为13.6%;临床分型为远端侧缘甲下型94例(58.39%),全甲毁损型43例(26.71%),白色浅表型18例(11.18%),近端甲下型6例(3.72%);菌种鉴定为皮肤癣菌属77例(67.54%),是主要的致病菌,酵母菌属(23.68%)和曲霉菌属(3.51%)相对要少;多因素分析结果表明年龄、男性、糖尿病病程、周围循环障碍、周围神经病变、视网膜病变与糖尿病患者患甲真菌病有关(P<0.05)。结论糖尿病患者甲真菌病的易感因素包括年龄、男性、糖尿病病程、周围循环障碍、周围神经病变、视网膜病变。 Objective To analyze the clinical classification, pathogenic fungal profile and predisposing factors of onychomycosis in patients with type 2 diabetes. Methods The analysis was performed basing on the clinical data of hospital patients with type 2 diabetes in department of endocrinology from January 2013 to August 2014. Assessed clinical classification and identifying fungi strains of the patients with onychomycosis. Analyzed the possible factors leading to incurrence of fungal infection in patients with type 2 diabetes and all these factors were statistics by Logistic regression analysis. Results A total of 1 125 cases of patients with type 2 diabetes were investigated and 153 patients had a fungal infection and the incidence rate of onychomycosis was 13.6%;DLSO were the most clinical classification (58.39%), followed by TDO (43 cases, 26.71%), SWO (18 cases, 11.18%) and PSO (6 cases, 3.72%); Dermatophytes were still the main pathogen and there were 77 patients infected by dermatophytes. Yeast (23.68%) and aspergillus (3.51%) were less than dermatophytes. Multi-factor analysis showed that age, male gender, duration of diabetes, peripheral circulatory disturbance, peripheral neuropathy, retinopathy were the predisposing factors of onychomycosis in patients with type 2 diabetes (P〈0.05). Conclusion The predisposing factors of onychomycosis in patients with type 2 diabetes include age, male gender, and duration of diabetes, peripheral circulatory disturbance, peripheral neuropathy and retinopathy.
出处 《中华临床医师杂志(电子版)》 CAS 2015年第9期80-84,共5页 Chinese Journal of Clinicians(Electronic Edition)
基金 山西医科大学博士基金(03200822)
关键词 糖尿病 2型 甲癣 致病菌 因果律 Diabetes mellitus, type 2 Onychomycosis Pathogen Causality
  • 相关文献

参考文献17

  • 1Welsh O,Vera-Cabrera L,Welsh E.Onychomycosis[J].Clin Dermatol,2010,28(2):151-159.
  • 2Mayser P,Freund V,Budihardja D.Toenail onychomycosis in diabetic patients:issue and management[J].Am J Clin Dermatol,2009,10(4):211-220.
  • 3甲真菌病诊治指南(2008年版)[J].中华皮肤科杂志,2008,41(12):844-845. 被引量:39
  • 4Whiting DR,Guariguata L,Weil C,et al.IDF diabetes atlas:global estimates of the prevalence of diabetes for 2011 and 2030[J].Diabetes Res Clin Pract,2011,94(3):311-321.
  • 5Papini M,Cicoletti M,Fabrizi V,et al.Skin and nail mycoses in patients with diabetic foot[J].G Ital Dermatol Venereol,2013,148(6):603-608.
  • 6Leelavathi M,Azimah MN,Kharuddin NF,et al.Prevalence of toenail onychomycosis among diabetics at a primary care facility in Malaysia[J].Southeast Asian J Trop Med Public Health,2013,44(3):479-483.
  • 7Boyko WL,Doyle JJ,Ryu S,et al.Onychomycosis and its impact on secondary infection development in the diabetic population[D].Presented at the 4th Annual International meeting of the International society for pharmacoeconomics and outcomes research(ISPOR),1999:23-26.
  • 8张雅洁,张桂梅,徐丹,熊峰,王新民.糖尿病患者趾甲真菌病的患病率及易感因素[J].中华皮肤科杂志,2004,37(4):212-214. 被引量:9
  • 9李玲琼,杨健,陈镜聪,梁瑞云,颜丽芬,高镇伟,何永林,杨一,张红娟.287例糖尿病病人甲真菌病流行病学调查[J].岭南皮肤性病科杂志,2007,14(1):54-55. 被引量:6
  • 10Gulcan A,Gulcan E,Oksuz S,et al.Prevalence of toenail onychomycosis in patients with type 2 diabetes mellitus and evaluation of risk factors[J].J Am Podiatr Med Assoc,2011,101(1):49-54.

二级参考文献12

  • 1Gupta AK, Konnikov N, MacDonald P, et al. Prevalence and epidemiology of toenail onychomycosis in diabetie subjects: a multicentre survey. Br J Dermatol, 1998, 139: 665-671.
  • 2Buxton PK, Milne LJ, Prescott R J, et al. The prevalence of dermatophyte infection in well-controlled diabetics and the response to Trichophyton antigen. Br J Dermatol, 1996, 134: 900-903.
  • 3Dogra S, Kumar B, Bhansali A, et al. Epidemiology of onychomycosis in patients with diabetes nellitus in India. Int J Dermatol, 2002,41: 647-651.
  • 4Sergeev IV, Serggv Al. Onychomycosis: the modern treatment approaches(Russian). New Medical Journal, 1997, 2: 25-28.
  • 5Gupta AK, Jain HC, Lynde CW, et al. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada--a multicenter survey of 2001 patients. Int J Dermatol, 1997, 36: 783-787.
  • 6Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol, 1992, 26(3 Pt 2):408-410.
  • 7Akanji AO, Adetuyidi A. The pattern of presentation of foot lesions in Nigerian diabetic patients. West Afr J Med, 1990, 9: 1-5.
  • 8Sigurgeirsson B,Steingrimosson O,Svein-sdottir S.Prevalence of onychomycosis in Iceland:a population -based study[J].Acta derm Venereol,2002,82 (6):467-469.
  • 9Sigurgeirsson B,Steingrimosson O.Risk factors associated with onychomycosis[J].J Eur Acad Dermatol,Venereol,2004,18 (1):48-51.
  • 10Haneke E,Rosceeuw D.The scope of onychomeosis:epidemiology and clinic feature[J].Int dermatol,1999,38(2):48 -51.

共引文献47

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部